Vaccines - STAT

Pharmalot By Ed Silverman

EU pushes rival plan to Covid-19 vaccine IP waiver, but some deride it as ‘meaningless’

Pharmalot By Ed Silverman

‘A perilous point’: Global agencies call for $50 billion investment to combat Covid-19

First Opinion By Hemal N. Sampat

Even fully vaccinated, people with organ transplants aren’t fully protected until more Americans get their shots

Opinions+ By Stephen Ferguson

SARS-CoV-2 brought the world to its knees. Its digital twin is helping bring us back

The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: Scott Gottlieb on Covid and grilling, plus how Zolgensma has changed SMA

Health By Lauran Neergaard — Associated Press

Moderna says its Covid-19 shot works in kids as young as 12

Pharmalot By Ed Silverman

Wealthy nations and drug makers offer moves to bridge Covid-19 vaccine divide

Pharmalot By Ed Silverman

Republican lawmakers tell Biden to reverse ‘disastrous decision’ to support Covid-19 IP waiver

Health By Matthew Herper

STAT+ Conversations: What statistics mean for the Covid-19 vaccines

Health By Helen Branswell

Sanofi, GSK announce positive early results for their Covid-19 vaccine candidate

Health By Megan Molteni

Mask mandates might be going away, but don’t ditch yours just yet, scientists caution

Health By Andrew Joseph

5 pressing questions about the New York Yankees’ breakthrough Covid-19 infections

First Opinion By Jonathan Doh

Make drug companies partners — not adversaries — to expand global Covid-19 vaccine access

Health By Elizabeth Cooney

‘It’s not over yet’: Uncertain protection from Covid vaccines leaves cancer patients in limbo

Pharmalot By Ed Silverman

Most Americans believe Biden is correct to support an IP waiver for Covid-19 vaccines

Health By Andrew Joseph

Vaccines seem to work well against coronavirus variants. It’s also complicated

Health By Helen Branswell

CDC advisory group gives green light to Pfizer’s Covid vaccine for adolescents

Health By Helen Branswell

FDA authorizes Pfizer’s Covid-19 vaccine for use in adolescents

Health By Lev Facher and Nicholas Florko

How David beat Goliath: Advocacy groups seized a moment, and found allies, in bid to loosen vaccine patent rights

Biotech By Jonathan Saltzman — Boston Globe

Moderna’s CEO says he ‘didn’t lose a minute of sleep’ over potential waiver of vaccine patents

The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: Vaccine riches, patent waivers, & a gene therapy for aging

Pharmalot By Ed Silverman

Pharmalittle: Biden supports WTO proposal on Covid-19 vaccine IP; Biogen Alzheimer’s drug is cost-effective at $2,500

First Opinion By Judith Chevalier and Jason L. Schwartz

Dollar stores: gateways to equitable Covid-19 vaccine distribution

Health By Damian Garde, Helen Branswell, and Matthew Herper

Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive

Pharmalot By Ed Silverman

Most Read

Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson

Catching Covid-19 after being vaccinated isn’t a myth. It happened to me

With the first dose, I need to be at peace with the vaccine. And let my body do the work

‘Authorization’ status is a red herring when it comes to mandating Covid-19 vaccination

In ‘vaccine apartheid,’ Nepal is ground zero. It needs U.S. help

Why would a Covid vaccine cause rare blood clots? Researchers have found clues

Shattering the infertility myth: What we know about Covid-19 vaccines and pregnancy

Is the Sputnik V vaccine too good to be true? Without the data, it’s hard to know

All Coverage

EU pushes rival plan to Covid-19 vaccine IP waiver, but some deride it as ‘meaningless’

‘A perilous point’: Global agencies call for $50 billion investment to combat Covid-19

Even fully vaccinated, people with organ transplants aren’t fully protected until more Americans get their shots

SARS-CoV-2 brought the world to its knees. Its digital twin is helping bring us back

Listen: Scott Gottlieb on Covid and grilling, plus how Zolgensma has changed SMA

Moderna says its Covid-19 shot works in kids as young as 12

Wealthy nations and drug makers offer moves to bridge Covid-19 vaccine divide

Republican lawmakers tell Biden to reverse ‘disastrous decision’ to support Covid-19 IP waiver

STAT+ Conversations: What statistics mean for the Covid-19 vaccines

Sanofi, GSK announce positive early results for their Covid-19 vaccine candidate

Mask mandates might be going away, but don’t ditch yours just yet, scientists caution

5 pressing questions about the New York Yankees’ breakthrough Covid-19 infections

Make drug companies partners — not adversaries — to expand global Covid-19 vaccine access

‘It’s not over yet’: Uncertain protection from Covid vaccines leaves cancer patients in limbo

Most Americans believe Biden is correct to support an IP waiver for Covid-19 vaccines

Vaccines seem to work well against coronavirus variants. It’s also complicated

CDC advisory group gives green light to Pfizer’s Covid vaccine for adolescents

FDA authorizes Pfizer’s Covid-19 vaccine for use in adolescents

How David beat Goliath: Advocacy groups seized a moment, and found allies, in bid to loosen vaccine patent rights

Moderna’s CEO says he ‘didn’t lose a minute of sleep’ over potential waiver of vaccine patents

Listen: Vaccine riches, patent waivers, & a gene therapy for aging

Pharmalittle: Biden supports WTO proposal on Covid-19 vaccine IP; Biogen Alzheimer’s drug is cost-effective at $2,500

Dollar stores: gateways to equitable Covid-19 vaccine distribution

Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive

U.S. will back proposal to waive intellectual property rights and boost Covid-19 vaccine production